Thermo Fisher reported revenue for the quarter grew 5% to $11.40 billion in 2024 versus the same quarter of 2023. Organic ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Thermo Fisher returned to growth in 4Q 2024 with 6.6% projected EPS growth. Learn why TMO stock’s leadership position and ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

Thermo Fisher Scientific Inc. closed 3.37% below its 52-week high of $627.88, which the company reached on September 10th.

The NanoDrop™ One/One C Microvolume UV-Vis Spectrophotometer from Thermo Fisher Scientific helps to avoid ... RNA contamination in dsDNA samples and chemical contaminants like phenol in RNA ...